2018
DOI: 10.1371/journal.pone.0193853
|View full text |Cite
|
Sign up to set email alerts
|

The effect of estrogenic compounds on psychosis-like behaviour in female rats

Abstract: 17β-estradiol treatment has shown benefit against schizophrenia symptoms, however long-term use may be associated with negative side-effects. Selective estrogen receptor modulators, such as raloxifene and tamoxifen, have been proposed as suitable alternatives to 17β-estradiol. An isomer of 17β-estradiol, 17α-estradiol, is considered less carcinogenic, and non-feminising in males, however little is known about its potential as a treatment for schizophrenia. Moreover, the mechanism underlying the therapeutic act… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 65 publications
2
12
0
Order By: Relevance
“…Specifically, contingency analysis demonstrated a near significant decrease in % PPI in Esr1 −/− compared with Esr1 +/+ . This may be related to the finding that a decrease in % PPI is observed in rodents following ovariectomy, an effect that is normalized with estradiol replacement (43, 44); thus, considering our results we postulate that this decrease is attributed to the actions of estradiol through ERα. In contrast with the effects of Esr1 deletion, female Esr2 −/− mice manifested higher PPI than their littermate controls suggesting an enhanced sensorimotor gating response.…”
Section: Discussionsupporting
confidence: 64%
“…Specifically, contingency analysis demonstrated a near significant decrease in % PPI in Esr1 −/− compared with Esr1 +/+ . This may be related to the finding that a decrease in % PPI is observed in rodents following ovariectomy, an effect that is normalized with estradiol replacement (43, 44); thus, considering our results we postulate that this decrease is attributed to the actions of estradiol through ERα. In contrast with the effects of Esr1 deletion, female Esr2 −/− mice manifested higher PPI than their littermate controls suggesting an enhanced sensorimotor gating response.…”
Section: Discussionsupporting
confidence: 64%
“…However, increasing evidence suggests that the beneficial effects of 17β-estradiol may also be in part conferred through the modulation of glutamatergic signaling 27,35,36 . This is supported by animal studies which show that 17β-estradiol enhances performance on a number of cognitive tasks, including attention and learning and memory tasks in healthy animals 27,28,54 as well as models of psychosis 30,[55][56][57] . Importantly, it is the ability of 17β-estradiol to modulate both glutamatergic and GABAergic systems that underlies these enhancing effects 45,48,[58][59][60][61] .…”
Section: Discussionmentioning
confidence: 74%
“…The role of female sex on ketamine effects and schizophrenia is controversial. Estrogens and progestogens in certain serum concentrations are protective factors against psychosis (van den Buuse et al, 2015; Sbisa et al, 2018). In adult schizophrenia, female sex is a much known protective factor, and estrogens are being tested successfully as an adjunctive therapy in women with schizophrenia (Kulkarni et al, 2015).…”
Section: Discussionmentioning
confidence: 99%